Information Technology [ 2/12 ] | Electronic Equipment, Instruments & Components [ 7/74 ]
NASDAQ | Common Stock
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions.
The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles.
The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.
The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016.
Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 5, 24 | 0.85 Increased by 0.00% | 0.85 |
| Aug 6, 24 | 0.73 Decreased by -8.75% | 0.69 Increased by +5.80% |
| May 7, 24 | 0.74 Increased by 0.00% | 0.58 Increased by +27.59% |
| Feb 28, 24 | 0.63 Decreased by -16.00% | 0.63 |
| Nov 7, 23 | 0.85 Increased by +4.94% | 0.74 Increased by +14.86% |
| Aug 8, 23 | 0.80 Increased by +2.56% | 0.73 Increased by +9.59% |
| May 9, 23 | 0.74 Increased by +1.37% | 0.64 Increased by +15.62% |
| Mar 1, 23 | 0.75 Increased by +11.94% | 0.72 Increased by +4.17% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 244.41 M Increased by +10.34% | 19.19 M Decreased by -9.57% | Increased by +7.85% Decreased by -18.04% |
| Jun 30, 24 | 235.86 M Increased by +2.79% | 13.76 M Decreased by -34.12% | Increased by +5.83% Decreased by -35.91% |
| Mar 31, 24 | 230.92 M Increased by +5.38% | 14.68 M Decreased by -19.65% | Increased by +6.36% Decreased by -23.75% |
| Dec 31, 23 | 211.57 M Decreased by -3.12% | 12.51 M Decreased by -18.03% | Increased by +5.91% Decreased by -15.39% |
| Sep 30, 23 | 221.50 M Decreased by -0.65% | 21.22 M Decreased by -5.63% | Increased by +9.58% Decreased by -5.01% |
| Jun 30, 23 | 229.46 M Increased by +6.55% | 20.88 M Increased by +19.45% | Increased by +9.10% Increased by +12.11% |
| Mar 31, 23 | 219.13 M Increased by +7.30% | 18.27 M Decreased by -2.95% | Increased by +8.34% Decreased by -9.55% |
| Dec 31, 22 | 218.37 M Increased by +9.76% | 15.26 M Increased by +10.96% | Increased by +6.99% Increased by +1.10% |